K. Okajima et al., Heterogeneity in the incidence and clinical manifestations of disseminatedintravascular coagulation: A study of 204 cases, AM J HEMAT, 65(3), 2000, pp. 215-222
The incidence and clinical manifestations of disseminated intravascular coa
gulation (DIC) were examined in patients with a range of underlying disorde
rs. Out of 1,882 patients suspected as having DIG, 204 cases were diagnosed
as suffering from DIC and included in this study. The underlying disorders
experienced by the patients were solid tumors (33.8%), hematologic maligna
ncies (12.7%), aortic aneurysm (10.8%), infections (6.4%), post-operative c
omplications (4.4%), liver disease (2.9%), obstetric disorders (2.5%), and
miscellaneous diseases (26.5%). The incidence of DIC was 10.8% out of all p
atients suspected of having DIG, and the etiologies were 10.9% in solid tum
ors, 10.1% in hematological malignancies, 20.4% in aortic aneurysm, 12.7% i
n infections, 15.5% in post-operative complications, 15.8% in liver disease
, 3.7% In obstetric disorders, and 9.8% in miscellaneous diseases. The clin
ical manifestations of DIC patients were varying dependent on their etiolog
ies. Most DIC patients with aortic aneurysm (95.5%) and postoperative compl
ications (88.9%) did not reveal any clinical manifestations. Although all o
f the patients with obstetric disorders had bleeding, only 20.0% of the pat
ients had organ failure. In contrast, although only 15.4% of the patients w
ith Infections had bleeding, 76.9% of these patients had organ failure. Ble
eding was observed in 31.9-50.0% of DIC patients with liver disease, hemato
logic malignancies, and solid tumors. Organ failure was observed in 21.7-33
.3% of DIC patients with liver disease, hematological malignancies, and sol
id tumors. Analysis by measurement of plasma levels of antiplasmin and plas
min-antiplasmin complex suggested that excessive fibrinolysis might contrib
ute to the development of bleeding in these DIC patients. Differences in pl
asma levels of thrombin-antithrombin complex and cross-linked fibrin degrad
ation products could not account for the differences in the incidence of or
gan failure in the patients. These findings suggest that the clinical manif
estation of DIC varies and might not only be a reflection of microthrombus
formation but also a reflection of the other underlying pathomechanisms. (C
) 2000 Wiley-Liss, Inc.